Dublin, May 08, 2018 -- The "Point-of-Care Diagnostics & Biosensors Europe 2018" conference has been added to ResearchAndMarkets.com's offering.
Point-of-Care Diagnostics Europe 2018 brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Agenda:
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low Cost POC Diagnostics Platforms for Deployment Worldwide
- POC Diagnostics for Global Health: A Worldwide Perspective
- POC Diagnostics in Cardiovascular Disease Testing
- Point-of-Care Diagnostics in Infectious Disease Testing
- Wearable and Implantable Devices
- Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing
For more information about this conference visit https://www.researchandmarkets.com/research/nqcksd/european?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology, Point-of-Care Diagnostics


U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 



